Trump import tariffs harm small businesses and consumers: increased costs and delays ahead

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829

Washington, DC – The National Consumers League (NCL) is deeply concerned about the Trump administration’s recent announcement of new tariffs on imports from Canada, Mexico, and China. NCL is fearful that this decision could significantly impact American consumers, affecting a wide range of goods that are integral to daily life.

As of this week, an agreement was made between the two North American countries to delay the tariffs for 30 days. This temporary pause allows time to see if these actions can lead to a solution without the need for harsh tariffs. If the agreements are not met or progress is not made, the tariffs could go back into effect after the 30-day period.

While these tariffs are framed as efforts to address national security concerns, the reality is that they could place an undue burden on everyday Americans. Consumers are already facing inflationary pressures, and these additional costs may only exacerbate the financial challenges that families and businesses face. The proposed 25% additional tariff on all imports from Canada and Mexico, along with a 10% tariff on energy resources, will directly drive-up prices on essential goods. NCL is concerned that consumers could feel the impact when they purchase everything from groceries to vehicles, as the increased tariffs is expected to add to the cost of manufacturing and transportation. An estimate from the non-partisan Tax Foundation puts the cost of the proposed tariffs at $800 per household this year.

“We are deeply concerned that these tariffs could hurt everyday Americans,” NCL CEO Sally Greenberg said. “Products consumers rely on daily, from fruits and vegetables to meat and energy could see price increases as supply chains are disrupted. Higher prices on basic goods would make life harder for families across the country, all as a result of these ill-conceived trade policies.”        

###

About the National Consumers League (NCL)

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

 

The power of polling: how data shapes campaigns and elections

/in , /by

February 6, 2025: On this episode of NCL’s “We Can Do this” podcast, National Consumers League CEO Sally Greenberg speaks with Democratic pollster Anna Greenberg, PhD, a senior partner at the polling firm GQR. Sally and Anna discuss polling techniques and polling results leading up to the election of President Donald Trump in 2024.

Read more

NCL joins 25+ advocacy organizations in opposing expansion of 340B drug pricing program in New York 

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829   

Washington, DC – Today, the National Consumers League (NCL) joined over 25 patient and provider advocacy organizations in voicing strong opposition to the proposed expansion of the 340B Drug Pricing Program under NY Senate Bill 1913. The groups, which represent a broad coalition of patients, healthcare providers, and consumer advocates, assert that the 340B program, originally designed to support vulnerable populations, has instead become a profit-driven mechanism benefiting large hospital systems and middlemen—without delivering on its promises to the low-income individuals it was meant to help.  

“The 340B program was designed to help vulnerable patients, but it’s become a profit-driven system that benefits hospitals, not those in need,” said Samantha Sears, Health Policy Associate at NCL. “It’s time for policymakers to demand real accountability and transparency.” 

Without these changes, 340B will continue to drive up costs while failing to serve those who need it most. Rather than expanding a flawed and dysfunctional system, the coalition is urging state legislators to take meaningful action to reform 340B. They are calling for: 

  • Greater transparency on how 340B savings are reinvested into patient care. 
  • Direct benefits to lower drug costs for uninsured patients. 
  • A focus on expanding the program in truly underserved areas. 

The full letter is available here. 

### 

About the National Consumers League (NCL)
The National Consumers League, founded in 1899, is America’s pioneer consumer organization.  Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad.  For more information, visit nclnet.org.

Fifteen organizations call on senate commerce committee to support TICKET Act  

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829  

Washington, DC – Today, the National Consumers League (NCL) joined a coalition of 15 organizations in support of the TICKET Act (S. 281). This bipartisan bill, reintroduced in the Senate by Senators Edward Markey (D-MA) and Eric Schmitt (R-MO), is scheduled for markup in the Senate Commerce Committee this Wednesday, February 5. NCL has championed this legislation since its introduction last Congress and continues to stand with numerous consumer and fan advocacy organizations and live event industry stakeholders in endorsing its key provisions.  

“Consumers deserve fair, transparent, and reliable ticketing practices, and the TICKET Act delivers just that,” said John Breyault, NCL Vice President of Public Policy, Telecommunications, and Fraud. “Hidden fees, speculative ticketing, and deceptive marketing practices have plagued the live event industry for far too long, leaving fans frustrated and out of pocket. The TICKET Act takes important steps toward fixing these issues, and NCL is proud to continue our support for this vital consumer protection legislation.”  

The TICKET Act requires all-in pricing, which would eliminate hidden fees and provide consumers with clear and transparent pricing upfront. It also bans speculative ticketing and deceptive marketing practices, ensures refunds for canceled or postponed events, and mandates a Federal Trade Commission (FTC) study on the enforcement of the BOTS Act.  

“The TICKET Act’s common-sense provisions will empower consumers and promote a more equitable and transparent live event ticketing marketplace,” said Breyault. “By supporting this bill, the Senate has the opportunity to protect millions of fans from deceptive practices and ensure that ticket buyers can confidently purchase tickets without fear of hidden costs or other unfair practices.” 

To view the organizations’ letter, click here. 

 ### 

About the National Consumers League (NCL)   

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org. 

NCL urges the public to heed warnings about unregulated versions of GLP-1 weight loss drugs

/in , , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829

Washington, DC — As an organization with a long history of helping the public avoid fakes and unregulated products, the National Consumers League (NCL) is urging consumers and health professionals to heed the warning from the Food and Drug Administration that compounded versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs now widely promoted on television and online are not FDA approved and may cause serious health problems.

Because studies show that FDA-approved anti-obesity medications (semaglutide and tirzepatide) can help individuals achieve significant weight loss, demand for GLP-1s has surged, prompting supply shortages and consumers to seek alternative ways to obtain these drugs because many health plans do not cover GLP-1s. This dynamic first opened the door for compounding pharmacies to sell non-identical versions of GLP-1 drugs under specific FDA regulations that apply when there is a shortage. Yet now, consumers are navigating a largely unregulated marketplace where numerous actors – telehealth companies, med-spas, illegal online pharmacies, and others – are marketing untested compounded GLP-1 drugs or actual counterfeits that, according to the FDA, may contain incorrect dosages, the wrong ingredients, too much, too little or none of the active ingredients, and possibly bacteria.

Underscoring the potential health consequences from dosing errors and exposure to the wrong ingredients, the FDA has received 607 adverse event reports related to compounded versions of semaglutide and tirzepatide as of November 24, 2024, many of which involve life-threatening and even deadly consequences. This includes approximately 10 deaths and over 100 hospitalizations from compounded semaglutide alone.

Besides the potential health risks, the National Association of Boards of Pharmacy (NABP) warns that illegal online pharmacies are selling substandard or falsified GLP-1 agonists without holding the required pharmacy licensure and without requiring a valid prescription. In fact, NABP has identified thousands of websites that promote the illegal sale of GLP-1 agonists, including sites that are connected to domain names that include GLP-1 drug’s brand names, including Ozempic and Wegovy. Additionally, NCL is aware of new research reported in the JAMA Health Forum, which finds that many websites for mass-produced compounded GLP-1 drugs do not include information about the drugs’ adverse effects, warnings, and contraindications, including hospitalizations, and use misleading language suggesting the compounded product is FDA-approved or equivalent to an FDA approved GLP-1 drug.

Recognizing that incorrect beliefs about obesity, misinformation about treatment options, and restrictive insurance policies keep Americans from getting quality obesity care, NCL and the National Council on Aging issued the first Obesity Bill of Rights for the nation, which establishes The Right to Accurate, Clear, Trusted, and Accessible Information as essential for informed decision-making. In furtherance of this right, NCL urges Americans to follow this advice from the FDA and obesity medicine specialists regarding compounded GLP-1 drugs:

  • Be aware that a compounded drug for obesity is not a copy of an FDA-approved GLP-1 drug. There are differences in how the different medicines are produced and often, the ingredients are different. Further, unapproved drugs have not gone through the FDA’s rigorous review process to ensure safety, effectiveness, and quality.
  • Before seeking treatment with an injectable GLP-1 drug, talk to your doctor or health provider to determine if you are a candidate for treatment with a GLP-1 based on your risk factors and degree of obesity. Also, ask questions about the differences between FDA-approved innovator drugs and off-brand compounded versions.
  • Because GLP-1 drugs are serious medicines that carry risks as well as benefits, it is best to obtain a prescription from your doctor or a health professional you know and fill the prescription at a state-licensed pharmacy.
  • In situations where you choose a telehealth option, beware of prescribing practitioners who do not take your personal history, do not diagnose the degree of obesity with appropriate evaluation measures, or prescribe a GLP-1 drug without ongoing monitoring.

Before ordering a compounded GLP-1 drug through an online pharmacy, follow the FDA’s tips to spot the warning signs that the website may be unsafe, such as the online pharmacy is not licensed in the US or by a state board of pharmacy and offers deep discounts that seem too good to be true.

### 

About the National Consumers League (NCL)   

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org. 

NCL strongly opposes the ‘Nullify Occupational Safety and Health Administration Act’ 

/in , , , /by

Washington, DC – Today, the National Consumers League (NCL) voices its strong opposition to the newly introduced legislation, the Nullify Occupational Safety and Health Administration Act, which seeks to abolish the Occupational Safety and Health Administration (OSHA). This legislation, introduced by Republican Congressman Andy Biggs, would repeal the landmark Occupational Safety and Health Act of 1970, eliminating vital federal workplace safety regulations. This would not only jeopardize the health and safety of millions of American workers but also threaten progress made in reducing workplace hazards.

“This bill would be a catastrophic step backward for worker safety in this country,” said NCL CEO Sally Greenberg. “Repealing OSHA would put workers at great risk by dismantling the very protections that have helped reduce workplace injuries and deaths for over 50 years. Without OSHA, many workers will be left vulnerable to unsafe conditions, and it will be the most vulnerable—low-income and minority workers—who will bear the brunt of dangerous rollbacks. Additionally, OSHA plays a crucial role in ensuring children’s safety in the workforce by holding corporations accountable and enforcing laws against dangerous, illegal labor practices. We need to build on the progress made in workplace safety, not dismantle it.”

For over fifty years, OSHA has been instrumental in safeguarding workers from hazardous conditions, significantly reducing workplace injuries, illnesses, and fatalities. When OSHA was founded in 1970, an estimated 14,000 workers were killed on the job each year, as compared with 5,283 fatal work injuries recorded in the U.S. in 2023, despite far more workers today. This is a remarkable track record of improving worker safety.

This is a direct result of OSHA’s regulations and oversight, saving countless lives. Mr. Biggs’ legislation threatens to undo these gains and will leave workers, including children, vulnerable to unsafe working conditions.

###

About the National Consumers League (NCL)

The National Consumers League, founded in 1899, is America’s pioneering consumer organization, dedicated to workers’ safety and the protection of children from labor exploitation. Our mission is to promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.